Vol 5, Supplement 4 (October 31, 2016): Translational Cancer Research

Mini-Review

The emerging role of chemokine receptor CXCR2 in cancer progression

Tanweer Jaffer, Daqing Ma

PDF Pages: S616-S628 Full Text (18339) COI Form Open Access

Editorial

Liquid biopsy in non-small cell lung cancer: come of age

Myung-Ju Ahn

PDF Pages: S629-S631 Full Text (3383) COI Form Open Access

The “liquid biopsy” in non-small cell lung cancer—not quite ready for prime time use

Angel Qin, Nithya Ramnath

PDF Pages: S632-S635 Full Text (4301) COI Form Open Access

Commentary on “A chimeric switch-receptor targeting PD1 augments the efficacy of second-generation CAR T cells in advanced solid tumors”

Richard A. Morgan

PDF Pages: S636-S639 Full Text (3730) COI Form Open Access

Is it useful to combine taxanes with targeted agents in mCRPC patients—have we hit the target in this phase II study with docetaxel and curcumin allowing going for a phase III study?

Elise Nassif, Constance Michel, Constance Thibault, Stéphane Oudard

PDF Pages: S640-S644 Full Text (3619) COI Form Open Access

Pathogenesis of acute gastroesophageal reflux disease might be changing

Naoya Yoshida, Yu Imamura, Yoshifumi Baba, Hideo Baba

PDF Pages: S645-S647 Full Text (3468) COI Form Open Access

Defining differential roles for microglia and infiltrating macrophages in the growth and neovascularization of glioma

Jeremy Tetsuo Miyauchi, Stella E. Tsirka

PDF Pages: S648-S651 Full Text (2327) COI Form Open Access

Immune infiltration, glioma stratification, and therapeutic implications

Manny D. Bacolod, Sarmistha Talukdar, Luni Emdad, Swadesh K. Das, Devanand Sarkar, Xiang-Yang Wang, Francis Barany, Paul B. Fisher

PDF Pages: S652-S656 Full Text (5245) COI Form Open Access

Can combination chemotherapy be standard therapy for sensitive relapsed small-cell-lung cancer?

Jung Soo Kim, Jeong-Seon Ryu

PDF Pages: S657-S658 Full Text (1682) COI Form Open Access

Chemotherapy plus intercalated or continuous EGFR-TKI in advanced non-small cell lung cancer

Antonio Rossi

PDF Pages: S659-S663 Full Text (3545) COI Form Open Access

miRNA based signature for predicting epithelial ovarian cancer relapse-progression: a step forward to prime time clinical adoption?

Lorenzo Ceppi, Sergio Marchini, Robert Fruscio

PDF Pages: S664-S667 Full Text (2975) COI Form Open Access

Immune checkpoint regulator: a new assignment proposed for the classic adhesion molecule P-selectin glycoprotein ligand-1

Jiaxuan Chen, Carolyn A. Haller, Elliot L. Chaikof

PDF Pages: S668-S671 Full Text (4533) COI Form Open Access

Tregs, Helios and tumor immunity: the sun has not yet risen

Angela M. Thornton, Ethan M. Shevach

PDF Pages: S672-S674 Full Text (5192) COI Form Open Access

Pancreatic cancer immunotherapy: coming of age

Irfana Muqbil, Ramzi M. Mohammad

PDF Pages: S675-S679 Full Text (2937) COI Form Open Access

Glioblastoma: does PET shed light to a difficult problem?

Jason M. Johnson, Caroline Chung

PDF Pages: S680-S683 Full Text (3109) COI Form Open Access

Hypofractionation for postoperative breast cancer radiotherapy: is acute toxicity a limiting factor?

Marco Krengli, Salvatore Terrazzino, Letizia Deantonio

PDF Pages: S684-S687 Full Text (3027) COI Form Open Access

Hypofractionated radiotherapy for breast cancer: too fast or too much?

Vassilis E. Kouloulias, Anna G. Zygogianni

PDF Pages: S688-S693 Full Text (5998) COI Form Open Access

The addition of bevacizumab to neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer, more not necessarily better

Humaid O. Al-Shamsi, Nuhad K. Ibrahim

PDF Pages: S694-S696 Full Text (2363) COI Form Open Access

Pancreatic cancer-derived exosomes: new role in paraneoplastic syndromes?

Chi Lam Au Yeung, Samuel C. Mok

PDF Pages: S697-S700 Full Text (2972) COI Form Open Access

What is the role of stereotactic body radiotherapy to treat inoperable hepatocellular carcinoma?

Susannah M. Cheek, David A. Geller

PDF Pages: S701-S702 Full Text (1741) COI Form Open Access

Radiofrequency ablation and stereotactic body radiotherapy as non-surgical options for hepatocellular carcinoma

Daniel Benjamin Gans, Sidhartha Tavri, Pablo Ros, Indravadan Patel

PDF Pages: S703-S707 Full Text (3856) COI Form Open Access

The potential of proteogenomics in oncology

Pamela Pinzani, Francesca Salvianti

PDF Pages: S708-S712 Full Text (2253) COI Form Open Access

Beyond genomics: biologic insights from the CPTAC proteogenomic analysis of breast cancer

Sandeep Rajput, Cynthia X. Ma

PDF Pages: S713-S715 Full Text (2169) COI Form Open Access

Intravenous and intraperitoneal paclitaxel with S-1: new hope for patients with pancreatic cancer and peritoneal metastases?

Willem Niesen, Oliver Strobel

PDF Pages: S716-S721 Full Text (9149) COI Form Open Access

Deciphering ZIC2/OCT4 signaling as a vulnerability in liver cancer stem cells

Stephanie Ma

PDF Pages: S722-S724 Full Text (3132) COI Form Open Access

Autophagy is required for PTEN-loss driven prostate cancer

David J. Barakat, Alan D. Friedman

PDF Pages: S725-S729 Full Text (3844) COI Form Open Access

Targeting pancreatic stellate cells to improve pancreatic cancer radiosensitivity

Vickna Balarajah, Cindy Neuzillet, Hemant M. Kocher

PDF Pages: S730-S737 Full Text (3517) COI Form Open Access

Resistance mechanisms in glioblastoma stem cells: finding opportunities in challenges

Tejpal Gupta

PDF Pages: S738-S741 Full Text (2361) COI Form Open Access

Shuttling towards a predictive assay for radiotherapy

Faissal Ouenzar, Michael J. Hendzel, Michael Weinfeld

PDF Pages: S742-S746 Full Text (2775) COI Form Open Access

Macrohistone H2A1 takes the center stage in cancer research as a regulator of stemness

Oriana Lo Re, Manlio Vinciguerra

PDF Pages: S747-S750 Full Text (3099) COI Form Open Access

Emerging role for USP1 in glioblastoma stem cell maintenance and radioresistance: a potential target for glioblastoma therapy

Quintino Giorgio D’Alessandris, Lucia Ricci-Vitiani

PDF Pages: S751-S754 Full Text (2680) COI Form Open Access

Exosomes containing adrenomedullin mediate new onset diabetes and weight loss in pancreatic cancer

Edward R. Sauter

PDF Pages: S755-S757 Full Text (2148) COI Form Open Access

Perspective

Role of the lncRNAs in malignant melanoma and their involvement in metastasis

Nejat Dalay

PDF Pages: S758-S764 Full Text (5275) COI Form Open Access

Apatinib for gastric cancer: are we moving the antiangiogenic strategy any forward?

Giuseppe Aprile, Marta Bonotto, Elena Ongaro, Silvio Ken Garattini, Valentina Fanotto, Debora Basile, Monica Cattaneo, Mariaelena Casagrande, Laura Ferrari, Giovanni Gerardo Cardellino, Paola Ermacora, Nicoletta Pella, Mariella Giovannoni, Gianpiero Fasola

PDF Pages: S765-S771 Full Text (4814) COI Form Open Access

Perspective on therapeutic application of selective internal radiotherapy in colorectal cancer liver metastasis

Mahdi Hussain Al Bandar, Nam Kyu Kim

PDF Pages: S772-S777 Full Text (2748) COI Form Open Access

A new fertility risk rating system for surgical, radiotherapy, and chemotherapy interventions used in testicular cancer

Jessica R. Walter, Mary E. Lohman, Shilajit D. Kundu, Shuai Xu

PDF Pages: S778-S781 Full Text (6867) COI Form Open Access

Glioblastoma stem cells differentiation through epigenetic modulation is driven by miR-296-5p/HMGA1/Sox2 axis

Veronica Ferrucci, Massimo Zollo

PDF Pages: S782-S788 Full Text (3582) COI Form Open Access

PIK3CA mutated, hormonal receptors and HER2: individual targets but partnered in the escape to targeted therapy in breast cancer

Joseph A. Pinto, Henry L. Gomez

PDF Pages: S789-S793 Full Text (4188) COI Form Open Access

Can we stop the progression of chronic liver disease to hepatocellular carcinoma?

Mark A. Feitelson

PDF Pages: S794-S799 Full Text (3735) COI Form Open Access

Genomic analysis of circulating tumor DNA to predict endocrine resistance and clonal evolution in patients with prostate cancer: Clinical perspectives and research opportunities

Dario Trapani, Giuseppe Curigliano

PDF Pages: S800-S802 Full Text (2015) COI Form Open Access

Emerging mutations and functional changes of androgen receptor associated with treatment resistance in prostate cancer

Filippo Martignano, Cristian Lolli, Giorgia Ravaglia, Valentina Gallà, Giorgia Gurioli, Samanta Salvi

PDF Pages: S803-S808 Full Text (6165) COI Form Open Access

New insights into patient radiosensitivity in relation to the biology of the ATM protein

David Murray, Razmik Mirzayans, Matthew Parliament

PDF Pages: S809-S814 Full Text (3476) COI Form Open Access

Is inhibiting the DNA damage response the answer to treatment resistance in glioma stem cells?

Patries M. Herst

PDF Pages: S815-S822 Full Text (4227) COI Form Open Access

Commentary

Diagnostic performance of [18F] fluorodeoxyglucose PET/CT and diffusion-weighted magnetic resonance imaging for the evaluation of treatment response to induction chemotherapy followed by definitive chemoradiotherapy in locally advanced head and neck squamous cell carcinoma

Jon Cacicedo, Arturo Navarro

PDF Pages: S823-S826 Full Text (2124) COI Form Open Access

Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5

Marianna Lucafò, Gabriele Stocco, Giuliana Decorti

PDF Pages: S827-S830 Full Text (3006) COI Form Open Access

A new angle on Notch combination therapies

Urban Lendahl

PDF Pages: S831-S835 Full Text (2670) COI Form Open Access

Intracranial activity of crizotinib: something to rely on?

Elizabeth Dudnik, Nir Peled

PDF Pages: S836-S838 Full Text (2810) Open Access

Selective FcγR engagement by human agonistic anti-CD40 antibodies

Peter Ellmark, Sara M. Mangsbo, Malin Lindstedt

PDF Pages: S839-S841 Full Text (4307) Open Access

New applications for deep sequencing of the T cell receptor repertoire in cancer patients

Alex H. Lee, Robert M. Prins

PDF Pages: S842-S843 Full Text (3403) COI Form Open Access

The prospective correlation between GGN and CAG repeat polymorphisms of androgen receptors and testicular cancer

Saima Shakil Malik, Nosheen Masood

PDF Pages: S844-S846 Full Text (2182) COI Form Open Access

The challenge for precision medicine: all tumor genomes are different and all cancer patients are different in their own way

Wei Cao, Fred G. Biddle, Hani Choudhry, Wei Wu

PDF Pages: S847-S851 Full Text (2833) COI Form Open Access

In vivo modeling of diffuse large B cell lymphoma (DLBCL) with the myeloid differentiation primary response gene 88 (MYD88) L265P mutationon

Vu N. Ngo

PDF Pages: S852-S854 Full Text (3975) COI Form Open Access

T cells exert force for pMHC pull-ups

Chenghao Ge, Muaz Nik Rushdi, Cheng Zhu

PDF Pages: S855-S857 Full Text (2274) COI Form Open Access

Perspective towards the clinical application of eribulin in soft tissue sarcomas

Piotr Rutkowski, Iwona Lugowska

PDF Pages: S858-S861 Full Text (2361) COI Form Open Access

Risk stratification in prostate cancer treated with radiation therapy: a window of opportunity for new clinical trials

Manuel Conson, Laura Cella, Roberto Pacelli

PDF Pages: S862-S864 Full Text (2120) COI Form Open Access

Prospecting for prostate cancer with precision medicine

Michelle M. Hill, Robert A. Gardiner

PDF Pages: S865-S867 Full Text (2066) COI Form Open Access

Novel therapeutic strategies against cancer and chronic infection by targeting P-selectin glycoprotein ligand-1 as an immune T cells response regulator

Elisa Ramos-Sevillano, Jose Yuste

PDF Pages: S868-S871 Full Text (3177) COI Form Open Access

The immunogenicity of cancer mutations and implications for T cell therapy

Diego Chowell, Timothy A. Chan

PDF Pages: S872-S874 Full Text (4853) COI Form Open Access

CIS is a negative regulator of IL-15-mediated signals in NK cells

Cristina Bottino, Alessandra Dondero, Alessandro Moretta, Roberta Castriconi

PDF Pages: S875-S877 Full Text (5161) Open Access

An unhealthy diet: making sense of a fatty niche for leukemia stem cells

Sébastien Jacquelin, Emma J. Dishington, Steven W. Lane

PDF Pages: S878-S881 Full Text (2571) Open Access

Vagus nerve-preserving distal gastrectomy may improve the quality of life after gastrectomy in early stage gastric cancer patients

Souya Nunobe, Takeshi Sano

PDF Pages: S882-S884 Full Text (2798) COI Form Open Access

Glutamine dependence and PIK3CA mutations in colon-rectal cancer cells: ATF4 enters the stage

Nicola Giuliani, Martina Chiu, Marina Bolzoni, Ovidio Bussolati

PDF Pages: S885-S888 Full Text (3717) COI Form Open Access

Is there any role for liver resection in the treatment of liver metastases from gastric carcinoma?

Nathan Grimes, Graeme Poston

PDF Pages: S889-S891 Full Text (1958) COI Form Open Access

Malignant pleural mesothelioma: beyond the mathematical models

Giovanni Leuzzi, Leonardo Duranti, Filippo Lococo

PDF Pages: S892-S894 Full Text (1735) COI Form Open Access

Phenotype: the result of a complex and still largely unknown interplay between molecules

Maria Maddalena Simile, Diego Francesco Calvisi, Gavinella Latte, Franceasco Feo, Rosa Maria Pascale

PDF Pages: S895-S897 Full Text (2182) COI Form Open Access

S-1: changing the facets of adjuvant chemotherapy in pancreatic cancer?

Lukas Perkhofer, Thomas J. Ettrich, Alexander Kleger

PDF Pages: S898-S902 Full Text (3767) COI Form Open Access

Breast cancer following childhood cancer—more to the story than we thought

Daniel A. Mulrooney

PDF Pages: S903-S906 Full Text (2212) COI Form Open Access

Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results?

Tom Wei-Wu Chen, Ching-Hung Lin, Chiun-Sheng Huang

PDF Pages: S907-S912 Full Text (4338) COI Form Open Access

MicroRNA master regulator of hematopoiesis may also hold the key to B-cell lymphoma pathogenesis and therapy

Charles H. Lawrie

PDF Pages: S913-S915 Full Text (1636) COI Form Open Access

Comparison of quantitative faecal immunochemical tests for haemoglobin (FIT) for asymptomatic population screening

Callum G. Fraser

PDF Pages: S916-S919 Full Text (4043) Open Access

Targeting the ubiquitin proteasome system in glioblastoma

Matthew K. Summers, Monica Venere

PDF Pages: S920-S922 Full Text (2411) COI Form Open Access

Radioprotective properties of myeloid-derived suppressor cells

Darren R. Cullinan, James C. Cripe, William G. Hawkins, S. Peter Goedegebuure

PDF Pages: S923-S925 Full Text (2607) COI Form Open Access

Correspondence

Targeting long non-coding RNAs (lncRNAs) with oligonucleotides in cancer therapy

Mark R. Pickard, Gwyn T. Williams

PDF Pages: S926-S927 Full Text (2665) COI Form Open Access

Novel mechanism of immune evasion involving PD-L1 in various cancers

Keisuke Kataoka, Seishi Ogawa

PDF Pages: S928-S929 Full Text (2818) Open Access

Challenges and opportunities of CYP3A5 as novel drug target in pancreatic cancer subtypes

Elisa M. Noll, Andreas Trumpp, Martin R. Sprick

PDF Pages: S930-S931 Full Text (2255) COI Form Open Access

The role of PET CT in the management of advanced nodal head neck cancer post chemoradiotherapy

Wai Lup Wong, Janet Dunn, Hisham Mehanna

PDF Pages: S932 Full Text (1808) COI Form Open Access

Tumor specific theranostic streptavidin-coupled superparamagnetic iron oxide nanoparticles for targeting therapeutic moieties in pancreatic cancer

Ujjwal M. Mahajan, Markus M. Lerch, Julia Mayerle

PDF Pages: S933-S935 Full Text (2313) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.